Preclinical Evaluation of Rho-Associated Protein Kinase Inhibitors in Keloid Disease Using 2D, 3D, and Ex Vivo Models

Preclinical Evaluation of Rho-Associated Protein Kinase Inhibitors in Keloid Disease Using 2D, 3D, and Ex Vivo Models – Abstract

Zeinab Ghasemishahrestani, Traci A. Wilgus, Nonhlanhla P. Khumalo, Ardeshir Bayat

Article Type: Conference Abstract

Download PDF File

METRICS

Preclinical Evaluation of Rho-Associated Protein Kinase Inhibitors in Keloid Disease Using 2D, 3D, and Ex Vivo Models 

Email Article


Zeinab Ghasemishahrestani1, Traci A. Wilgus 2 ,Nonhlanhla P. Khumalo1 ,Ardeshir Bayat1

  1. MRC-SA Wound Healing & Keloid Research Unit and National Research Foundation (SARChI Chair), Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
  2. Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH 43210, USA.

Running Title

Preclinical Evaluation of Rho-Associated Protein Kinase Inhibitors in Keloid Disease  Using 2D, 3D, and Ex Vivo Models


Word Count

357 Words

The full text of this article is for subscribers. The title and abstract remain free to read.

View subscription plans Log in Create an account